Home Life Sciences The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
Article Open Access

The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer

  • , , , , , and EMAIL logo
Published/Copyright: September 14, 2018
Download Article (PDF)
Open Life Sciences
From the journal Open Life Sciences Volume 13 Issue 1

Abstract

Background

To analyze the application value of apparent diffusion coefficient (ADC) and exponent apparent diffusion coefficient (EADC) in evaluating the efficacy of radiation and chemotherapy in cervical cancer using pre- and posttreatment diffusion-weighted magnetic resonance imaging (DW-MRI) scans.

Methods

52 patients with cervical cancer were administered radiation and chemotherapy. Both MRI and DW-MRI were obtained at different stages. The ADC and EADC values, as well as the maximum tumor diameter, were measured and analyzed.

Results

We found that the ADC value increased after treatment, and the EADC value decreased. Changes in the calculated ADC occurred earlier than the morphologic changes of the tumors. A negative correlation was detected between reduced rates in the maximum tumor diameter two months after treatment and pretreatment ADC value (r = –0.658, P < 0.05). An ROC curve and nonlinear regression analysis showed that the formula, y = (1525500.122x2 – 4689.962x + 3.482) × 100%, can be used to calculate the percentage of complete remission after treatment according to the pretreatment ADC value.

Conclusion

Our data suggest that pretreatment ADC and EADC values are predictive of the efficacy of radiation and chemotherapy. Both ADC and EADC values during treatment were instrumental in early monitoring and dynamic observation.

Keywords: Cervical Cancer; Diffusion-Weighted Imaging (DWI); Radiation; Chemotherapy

1 Introduction

Cervical cancer is one of the most common malignancies of the genital tract in women. With the implementation of cervical screening programs, such as the Pap test, and HPV DNA test, the incidence of cervical cancer in developed countries has decreased; however, it remains the third most common cancer in developing countries [1]. Persistent, recurrent, and metastatic cervical cancers have a poor prognosis, so cervical cancer is still a major cause of morbidity and mortality for women [2]. Multiple therapeutic modalities have been used to treat cervical cancers, including surgery, concurrent chemoradiation, targeted therapy, cell-based therapy, combined siRNA, chemotherapy, and immunotherapy [3]. In general, early-stage cervical cancer is mainly treated with surgery; however, concomitant radiochemotherapy is typically the first choice for intermediate-stage and terminal cervical cancers [4, 5].

In fact, radioresistance and drug resistance are major obstacles for patients with cervical cancer. By enhancing sensitivity, it is hoped that lower doses of radiation and drugs, will increase the survival rate and improve the quality of life [4]. A means of forecasting and monitoring the radio- and chemosensitivity for cervical cancers has become an intense area of clinical research. Studies have shown that radiosensitivity of cervical cancer is related to the apoptosis of cervical cancer cells, and mainly depends on the balance between pro- and antiapoptotic proteins. The expression of Bcl2, Bax, and p53 in cancer cells is related to the sensitivity to radiation therapy [4, 6,7,8]. Tumor hypoxia is also associated with radioresistance, suggesting that monitoring and manipulating the level of tumor hypoxia would be helpful for the treatment of cervical cancer and prediction of the prognosis [9,9,10,11]. Temperature also influenced the treatment effect of cancers. Interestingly, hypothermia enhanced human tumor cell radiosensitivity [12].

Studies have shown that the diffusion properties of water vary in areas of necrosis, high cellularity, inflammation, and fibrosis. Based on this mechanism, quantitative analysis of water diffusion in diseased tissues would be helpful to diagnose and predict the prognosis of diseases. Diffusion-weighted imaging (DWI) is an MRI technique widely used to quantify the movement of water molecules at a cellular level [13, 14]. Recent studies have shown that DWI could be used for the detection cancers, staging and follow-up after treatment [15, 16]. DWI can also be used to differentiate true progression and pseudoprogression of tumors after chemoradiotherapy [17, 18]. In this study, we explored the predictive value of DWI on the efficacy of radiation and chemotherapy in patients with cervical cancer.

2 Materials and Methods

2.1 Study patients

Patients with cervical cancer (n = 52) were administered concomitant radiochemotherapy in the Affiliated Hospital of Qingdao University from January 2012 to November 2014. Cervical cancers included squamous carcinoma (n = 48) and adenocarcinoma (n = 4). The average patient age was 53.3 ± 2.4 years (range, 37-75 years). The average maximum diameter was 47.2 ± 3.8 mm (range, 23-89 mm). Patients who underwent treatment prior to admission were excluded from this study.

Informed consent: Informed consent has been obtained from all individuals included in this study.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

2.2 Radiotherapy planning and chemotherapy regimen

All patients received concurrent chemoradiotherapy. The chemotherapy regimen was a TP (Taxol+ Cisplatin) scheme based on platinum. In detail, Cisplatin (50-70mg/m2) and Taxol aclitaxel (135-175mg/m2) were administered through intravenous drip for one to two courses. The treatment course was 4 weeks. The radiation regimen (5 times per week and 2 Gy per dosing) lasted for two weeks and the total dosage was 20 Gy.

2.3 MRI and DWI

Imaging patients was performed using a GE Signa 3.0T MR. Scanning and DWI examinations were performed at different stages, including pretreatment, 15 days after treatment, and at 1 and 2 months following treatment. Patients fasted 8–12 h before the examination. Scanning areas included the superior border of the ilium to the lower margin of the pubic bone. Imaging parameters were as follows: axial T1W TR, 300–600 ms; TE, 2–20 ms; T2W TR, 2000–8000 ms; TE, 80–150 ms; coronal T2W TR, 2000–8000 ms; TE, 80–150 ms; axial DWI TR, 2000–8000 ms; TE, 80–150 ms; depth, 6 mm; interlayer spacing, 2 mm; matrix, 230 × 256; FOV, 40 × 40; NEX, 4 times; and b value, 0.800 s/mm2.

2.4 Imaging post-processing and measurement

The original data were uploaded to an AW 4.3 workstation and Functool software was used for further analysis. According to T2WI and DWI imaging, signal homogeneity for the ADC was selected as the region of interest (ROI), and the ADC and EADC values were measured. Based on the response evaluation criteria in solid tumors (RECIST), cases were divided into complete remission (CR), partial remission (PR), and stable disease (SD) [19].

2.5 Statistical analyses

Two independent sample t-test, random analysis of variance, and a Pearson correlation analysis between the 2 variables were used to analyze the data using SPSS 19.0. A p value of <0.05 was regarded as significant.

3 Results

3.1 Prediction of ADC for treatment efficacy in cervical cancer

Two months after treatment, MR scans showed that tumors had completely disappeared in 9 patients (CR group); partial remission was observed in 42 patients (PR group, at least a 30% decrease in the maximum tumor diameter). Less than a 30% decrease was observed in 1 patient (SD group). We did not analyze the SD group due to the small number of samples. The ADC and EADC values for the different time periods (pretreatment, 15 days after treatment, 1 month after treatment, and 2 months after treatment) are shown in Table 1. There were significant differences observed in the ADC and EADC values between the CR and PR groups before treatment (p < 0.05). However, no differences in ADC and EADC values were seen between CR and PR groups during and posttreatment scan. In both groups, the ADC value increased after treatment, but the EADC value decreased. The maximum ADC value in the CR group before treatment was 0.895 × 10−3 mm2/s. The minimum EADC value in the CR group before treatment was 0.489. The minimum ADC value in the PR group before treatment was 0.754 × 10−3 mm2/s. The maximum EADC value in the PR group before treatment was 0.547.

Table 1

ADC value and EADC value in different stages of treatment

StagesCR GroupPR Group
ADC value (×10-3mm2/s)EADC valueADC value (×10-3mm2/s)EADC value
Pretreatment0.764±0.0730.546±0.0330.986±0.0490.457±0.018
15 days after treatment1.703±0.044[**]0.258±0.009[*]1.577±0.047[**]0.289±0.012[**]
One month after treatment1.730±0.024[**]0.251±0.005[*]1.674±0.025[**]0.261±0.005[**]
Two month after treatment1.799±0.035[**]0.237±0.007[*]1.752±0.009[**]0.246±0.002[**]

  1. VS before treatment

Figure 1 Relationship between the probability of CR and pretreatment ADC value
Figure 1

Relationship between the probability of CR and pretreatment ADC value

Figure 2 Representative image of cervical squamous cell carcinoma, 45-year-old female; A, B, and C are T2WI images of the patient in a sagittal position before treatment, 15 days after treatment, and 2 months after treatment, respectively. The tumor was noticeably reduced.
Figure 2

Representative image of cervical squamous cell carcinoma, 45-year-old female; A, B, and C are T2WI images of the patient in a sagittal position before treatment, 15 days after treatment, and 2 months after treatment, respectively. The tumor was noticeably reduced.

An ROC curve analysis for the ADC is shown in Table 2. The value of the state variable was selected from the PR group. After ROC curve analysis, the maximum point for Youden’s index (YI) was analyzed using the ROC curve and was designated as the diagnosis point. The ADC value at this point was 0.891 × 10−3 mm2/s, and the YI was 0.794. If the ADC value was less than, or equal to the diagnosis point, it implied that the tumor would completely disappear after treatment. If the ADC value was greater than the diagnosis point, it implied that a CR would be difficult to achieve for a patient with this tumor.

Table 2

ROC curve analysis of ADC

ParameterAUCStandard errorP value95% confidence intervalsThreshold (×10-3mm2/s)Sensitivity (%)Specificity (%)
ADC0.9020.0460.0000.812~0.9910.89184.495.0

The significance of the ADC value in the CR and PR groups was assessed in a discriminant analysis, curve estimation, and nonlinear regression analysis to determine the probability that the ADC value can help predict the CR of tumors. The formula, y = (1525500.122x2 – 4689.962x + 3.482) × 100%, can be used to calculate the percentage of CR after treatment according to the pretreatment ADC value. X represents the pretreatment ADC value (mm2/s). Y represents the percentage of CR. The standard error was 0.079, and the probability of PR was equal to 1 – Y.

3.2 Correlation between tumor diameter and the ADC and EADC values

The average value of the maximum tumor diameter at different stages is shown in Table 3. There was no apparent difference between 15 days after treatment and pretreatment. However, after 1 month and 2 months, the maximum tumor diameter had decreased. The ADC value increased after treatment and the EADC value decreased. The difference in the ADC and EADC values was identified 15 days after treatment and morphological changes occurred after the ADC and EADC values had changed. The average ADC value for the 52 patients before treatment was (0.944 ± 0.046) × 10−3 mm2/s. After 2 months, the decreased ratio of the maximum tumor diameter was 85.69 ± 2.38%. A negative correlation was observed between the decreased maximum tumor diameter 2 months after treatment and pretreatment ADC value (r = –0.658, P < 0.05). The increase in ADC values was 40.24 ± 3.24% and 44.03 ± 2.51% at 15 days and 1 month after treatment, respectively. The ADC values were positively correlated with the reduction ratio of the maximum tumor diameter after 2 months (r = 0.783, p = 0.000; r = 0.676, p = 0.001, respectively).

Table 3

ADC value, EADC value and the maximum tumor diameter

StagesADC value (×10-3mm2/s)EADC valueMaximum tumor diameter (mm)
Pretreatment0.944±0.0460.474±0.01747.21±3.83
15 days after treatment1.601±0.040[**]0.283±0.010[**]46.86±3.77
One month after treatment1.685±0.097[**]0.259±0.004[**]21.57±1.50[**]
Two month after treatment1.761±0.047[**]0.244±0.002[**]6.48±1.09[**]

4 Discussion

Radiological imaging techniques are widely used to evaluate the posttreatment tumor response; however, this evaluation is dependent on the reduction in tumor size after treatment [20].

Interestingly, the increased use of targeted therapies in advanced cancer, which typically induces necrosis and cavitation, does not consistently reduce tumor size. Thus, traditional anatomical methods are not efficient to evaluate treatment efficacy [21]. DWI is a newly developed MRI technique that provides functional information regarding the behavior of water molecules in tissues [22]. Studies have shown that DWI holds promise in cancer diagnosis and outcome prediction [23,24,25]. In cervical cancer, DWI improved the prediction of disease progression after concurrent chemoradiotherapy (CCRT), along with T2WI [26]. As a promising tool for functional imaging, studies of cell and animal models also showed that DWI has the potential to help predict the effect of different treatments on tumors [27,28,29,30].

In this study, we found that the ADC value in cervical cancer was increased 15 days after treatment and that the EADC value was decreased. However, the maximum tumor diameter had no apparent changes, indicating that the ADC and EADC values changed before the tumor volume changed. After 15 days, there was a negative correlation between the decreased maximum tumor diameter and ADC value, suggesting that the ADC value is also an indicator of tumor diameter. In our study, the results also showed there were significant differences in the ADC and EADC values between the CR and PR groups before treatment. In fact, CR and PR groups were grouped according to the extent of tumor shrinkage, but not histopathology. There were no differences of ADC and EADC values between CR and PR groups during and posttreatment scan. This inconsistency may be related to the histopathology.

The theoretical basis of DWI in distinguishing between normal and tumor tissues lies within the difference between water diffusion in the different tissues [28]. The density of cells is also related to DWI signals and ADC values [31]. Naganawa et al. showed that the average ADC value for cervical lesions and normal cervical tissues was 1.09 ± 0.20 × 10−3 and 1.79 ± 0.24 × 10−3 mm2/s, respectively [32]. Malignant cells proliferate robustly, and the water content inside and outside cells is increased. Protein adsorption of water is enhanced, and the volume of cells is consequently increased, and the effective movement of water in tumors is limited. Thus, the DWI signal increases, and the ADC value decreases [33]. After effective treatment, cells die or undergo apoptosis. As the integrity of the cell membrane disappears, extracellular space is increased and the density of cells decreases. The DWI signal decreased, and the ADC value increased [34]. Killing of malignant cells and protection of normal cells is the purpose of treatment. Certainly, functional changes precede morphologic changes [35], and early assessment is feasible with DWI before changes are apparent in the tumor size. Since the ADC value of tumors is linked to their growth rates and remission after treatment, it can be used to predict the sensitivity of tumors to treatment [36]. Following treatment, the ADC value of the cervical tumors returns to normal[32]. DWI can be easily assessed and is more rapid. Combined with other methods, the ADC value certainly has a significant clinical value for the early monitoring of cervical cancers [37, 38]

In this study, we also analyzed the maximum point of YI using an ROC curve that was defined as the diagnosis point. The ADC value at this point was 0.891 × 10−3 mm2/s and the YI was 0.794. If the ADC value was less than or equal to the diagnosis point, it implied that the tumor would completely disappear after treatment. If the ADC value was greater than the diagnosis point, it implied that CR would be difficult to achieve. To further analyze the probability that the ADC value could predict the ability of a tumor to achieve a CR, the significant ADC value in the CR and PR groups was assessed using a discriminant analysis, curve estimation and nonlinear regression. The derived formula, y = (1525500.122x2- 4689.962x + 3.482) × 100%, could be used to calculate the likelihood of CR after treatment according to the pretreatment ADC value. A standard error of 0.079 was calculated. According to the formula, the probability of CR could be determined. It holds great value in predicting the sensitivity of cervical cancers to radiation and chemotherapy. In fact, Meng J et al reported that pre- and mid-treatment whole-lesion ADC histogram and texture analysis hold great potential in predicting tumor recurrence of advanced cervical cancer treated with concurrent chemo-radiotherapy [39]. Certainly, our results and other studies suggest ADC value and EADC values are useful for the prediction of cervical cancer treatment efficacy and recurrence.

Although there were limitations in this study, including the small number of samples, and subjectivity in measuring the diameter of tumors, our data warrant further study using a larger number of samples and optimized measuring criteria to explore a new grouping standard. Indeed, our data provide strong evidence for the quantitative prognostic value of ADC and EADC during cervical cancer treatment.

5 Conclusion

In this study, we observed that changes in ADC values preceded changes that occurred in tumors after treatment. We also found that pretreatment ADC and EADC values could be used to predict the efficacy of radiation and chemotherapy. The results from our study further underscore the instrumental use of ADC and EADC values during treatment during early monitoring and dynamic observation.

  1. Conflict of interest: Authors state no conflict of interest.

References

[1] Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, et al. Cervical cancer: screening, diagnosis and staging. J BUON, 2016;21(2):320-5.Search in Google Scholar

[2] Bizzarri N, Ghirardi V, Alessandri F, Venturini PL, Valenzano MM. Bevacizumab for the treatment of cervical cancer. Expert Opin Biol Ther, 2016;16(3):407-19.10.1517/14712598.2016.1145208Search in Google Scholar

[3] Yee GP, de Souza P, Khachigian LM. Current and potential treatments for cervical cancer. Curr Cancer Drug Targets, 2013;13(2):205-20.10.2174/1568009611313020009Search in Google Scholar

[4] Qin C, Chen X, Bai Q, Davis MR, Fang Y. Factors associated with radiosensitivity of cervical cancer. Anticancer Res, 2014;34(9):4649-56.Search in Google Scholar

[5] Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer, 2007;17(4):833-42.10.1111/j.1525-1438.2007.00895.xSearch in Google Scholar

[6] Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia, 2002;4(4):295-303.10.1038/sj.neo.7900251Search in Google Scholar

[7] Ohno, T., Nakano T, Niibe Y, Tsujii H, Oka K. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma. Cancer, 1998, 83(1):103-10.10.1002/(SICI)1097-0142(19980701)83:1<103::AID-CNCR14>3.0.CO;2-0Search in Google Scholar

[8] Mukherjee G, Freeman A, Moore R, Kumaraswamy, Devi KU, Morris LS, et al. Biologic factors and response to radiotherapy in carcinoma of the cervix. Int J Gynecol Cancer, 2001;11(3):187-93.10.1046/j.1525-1438.2001.01014.xSearch in Google Scholar

[9] Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist, 2004;9 Suppl 5:31-40.10.1634/theoncologist.9-90005-31Search in Google Scholar

[10] Suzuki Y, Nakano T, Ohno T, Kato S, Niibe Y, Morita S, et al.. Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer. Int J Gynecol Cancer, 2006;16(1):306-11.10.1111/j.1525-1438.2006.00341.xSearch in Google Scholar

[11] Dehdashti, F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys, 2003;55(5):1233-8.10.1016/S0360-3016(02)04477-2Search in Google Scholar

[12] Burton SA, Paljug WR, Kalnicki S, Werts ED. Hypothermia-enhanced human tumor cell radiosensitivity. Cryobiology, 1997;35(1):70-8.10.1006/cryo.1997.2027Search in Google Scholar

[13] Boone D, Taylor SA, Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis, 2013;15(6):655-61.10.1111/codi.12241Search in Google Scholar PubMed

[14] Wilhelm T, Stieltjes B, Schlemmer HP. Whole-body-MR-diffusion weighted imaging in oncology. Rofo, 2013;184(10):950-8.10.1055/s-0033-1335428Search in Google Scholar PubMed

[15] Malayeri AA, El Khouli RH, Zaheer A, Jacobs MA, Corona-Villalobos CP, Kamel IR, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics, 2011;31(6):1773-91.10.1148/rg.316115515Search in Google Scholar PubMed

[16] Cao K, Gao M, Sun YS, Li YL, Sun Y, Gao YN, et al. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness. Eur J Radiol 2012;81(8):1926-30.10.1016/j.ejrad.2011.04.019Search in Google Scholar PubMed

[17] Lee WJ, Choi SH, Park CK, Yi KS, Kim TM, Lee SH, et al. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas. Acad Radiol, 2012;19(11):1353-61.10.1016/j.acra.2012.06.011Search in Google Scholar PubMed

[18] Yoo RE, Choi SH, Kim TM, Lee SH, Park CK, Park SH, et al. Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value. AJNR Am J Neuroradiol, 2015;36(10):1846-52.10.3174/ajnr.A4401Search in Google Scholar PubMed PubMed Central

[19] Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009;45(2):228-47.10.1016/j.ejca.2008.10.026Search in Google Scholar PubMed

[20] Marcus CD, Ladam-Marcus V, Cucu C, Bouché O, Lucas L, Hoeffel C. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol, 2009;72(3):217-38.10.1016/j.critrevonc.2008.07.012Search in Google Scholar PubMed

[21] Heijmen L, Verstappen MC, Ter Voert EE, Punt CJ, Oyen WJ, de Geus-Oei LF, et al. Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use? Crit Rev Oncol Hematol, 2012;83(2):194-207.10.1016/j.critrevonc.2011.12.008Search in Google Scholar PubMed

[22] Ibrahiem EI, Mohsen T, Nabeeh AM, Osman Y, Hekal IA, Abou El-Ghar M. DWI-MRI: single, informative, and noninvasive technique for prostate cancer diagnosis. Scientific World Journal, 2012;2012:973450.10.1100/2012/973450Search in Google Scholar PubMed PubMed Central

[23] Hauser T, Essig M, Jensen A, Laun FB, Münter M, Maier-Hein KH, et al. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. Eur J Radiol, 2014;83(5):783-7.10.1016/j.ejrad.2014.02.013Search in Google Scholar

[24] Lei J, Tian Y, Zhu SC, Han Q, Wei Y, Yang S, et al. Preliminary study of IVIM-DWI and DCE-MRI in early diagnosis of esophageal cancer. Eur Rev Med Pharmacol Sci, 2015;19(18):3345-50.Search in Google Scholar

[25] Joye I, Deroose CM, Vandecaveye V, Haustermans K. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol, 2014;113(2):158-65.10.1016/j.radonc.2014.11.026Search in Google Scholar

[26] Park JJ, Kim CK, Park BK, Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging. Eur Radiol, 2016;26(9):3272-9.10.1007/s00330-015-4156-7Search in Google Scholar

[27] Heo SH, Shin SS, Kim JW, Lim HS, Jeong YY, Kang WD, et al. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Korean J Radiol, 2013;14(4):616-25.10.3348/kjr.2013.14.4.616Search in Google Scholar

[28] She D, Yang X, Xing Z, Cao D. Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging. AJNR Am J Neuroradiol, 2016.10.3174/ajnr.A4809Search in Google Scholar

[29] Makino H, Kato H, Furui T, Morishige K, Kanematsu M. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer. J Obstet Gynaecol Res, 2014;40(4):1098-104.10.1111/jog.12276Search in Google Scholar

[30] Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, et al. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging, 2015;33(2):201-12.10.1016/j.mri.2014.08.041Search in Google Scholar

[31] Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology, 2002;224(1):177-83.10.1148/radiol.2241010637Search in Google Scholar

[32] Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol, 2005;15(1):71-8.10.1007/s00330-004-2529-4Search in Google Scholar

[33] Xue HD, Li S, Sun F, Sun HY, Jin ZY, Yang JX, et al. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer. Chin Med Sci J, 2008;23(3):133-7.10.1016/S1001-9294(09)60027-4Search in Google Scholar

[34] Rizzo S, Summers P, Raimondi S, Belmonte M, Maniglio M, Landoni F, et al. Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy. Radiol Med, 2011;116(5):766-80.10.1007/s11547-011-0650-4Search in Google Scholar PubMed

[35] Bae JM, Kim CK, Park JJ, Park BK. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy? Abdom Radiol (NY), 2016.10.1007/s00261-016-0730-ySearch in Google Scholar PubMed

[36] Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol, 2008;111(2):213-20.10.1016/j.ygyno.2008.07.048Search in Google Scholar PubMed

[37] Mahajan A, Engineer R, Chopra S, Mahanshetty U, Juvekar SL, Shrivastava SK, et al. Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers. Eur J Radiol Open, 2016;3:22-30.10.1016/j.ejro.2015.11.003Search in Google Scholar PubMed PubMed Central

[38] Xie H, Sun T, Chen M, Wang H, Zhou X, Zhang Y, et al.. Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer: a systematic review and meta-analysis. Medicine (Baltimore), 2015;94(6):e517.10.1097/MD.0000000000000517Search in Google Scholar PubMed PubMed Central

[39] Meng J, Zhu L, Zhu L, Xie L, Wang H, Liu S, et al. Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT.Oncotarget. 2017;8(54):92442-92453.10.18632/oncotarget.21374Search in Google Scholar PubMed PubMed Central

Received: 2017-11-23
Accepted: 2018-05-08
Published Online: 2018-09-14

© 2018 Jingjing Chen et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Research Article
  2. Purification of Tea saponins and Evaluation of its Effect on Alcohol Dehydrogenase Activity
  3. Runt-related transcription factor 3 promoter hypermethylation and gastric cancer risk: A meta-analysis
  4. Risk Factors for Venous Thromboembolism in Hospitalized Patients in the Chinese Population
  5. Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism
  6. A new combination of substrates: biogas production and diversity of the methanogenic microorganisms
  7. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
  8. Direct Effects on Seed Germination of 17 Tree Species under Elevated Temperature and CO2 Conditions
  9. Role of water soluble vitamins in the reduction diet of an amateur sportsman
  10. Aberrant DNA methylation involved in obese women with systemic insulin resistance
  11. 16S ribosomal RNA-based gut microbiome composition analysis in infants with breast milk jaundice
  12. Characterization of Haemophilus parasuis Serovar 2 CL120103, a Moderately Virulent Strain in China
  13. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45
  14. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
  15. Optimizing the Formulation for Ginkgolide B Solid Dispersion
  16. Determination of the In Vitro Gas Production and Potential Feed Value of Olive, Mulberry and Sour Orange Tree Leaves
  17. Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells
  18. The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
  19. Chemical profile and antioxidant activity of Trollius europaeus under the influence of feeding aphids
  20. SSR Markers Suitable for Marker Assisted Selection in Sunflower for Downy Mildew Resistance
  21. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
  22. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
  23. Microbial indicators and environmental relationships in the Umhlangane River, Durban, South Africa
  24. TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
  25. Long non-coding RNA-2271 promotes osteogenic differentiation in human bone marrow stem cells
  26. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid
  27. Risk expansion of Cr through amphibious clonal plant from polluted aquatic to terrestrial habitats
  28. Overexpression of Zinc Finger Transcription Factor ZAT6 Enhances Salt Tolerance
  29. Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
  30. Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
  31. A Preliminary Study on the Newly Isolated High Laccase-producing Fungi: Screening, Strain Characteristics and Induction of Laccase Production
  32. Hydrolytic Enzyme Production by Thermophilic Bacteria Isolated from Saudi Hot Springs
  33. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  34. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/ AKT pathways
  35. Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer
  36. Inhibitory activities of ethanolic extracts of two macrofungi against eggs and miracidia of Fasciola spp.
  37. PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
  38. Characterization of a potential ripening regulator, SlNAC3, from Solanum lycopersicum
  39. Expression of Angiopoietin and VEGF in cervical cancer and its clinical significance
  40. Umbilical Cord Tissue Derived Mesenchymal Stem Cells Can Differentiate into Skin Cells
  41. Isolation and Characterization of a Phage to Control Vancomycin Resistant Enterococcus faecium
  42. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
  43. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
  44. Relationship between climate trends and grassland yield across contrasting European locations
  45. Review Articles
  46. Mechanisms of salt tolerance in halophytes: current understanding and recent advances
  47. Salivary protein roles in oral health and as predictors of caries risk
  48. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
  49. Survival mechanisms to selective pressures and implications
  50. Up-regulation of key glycolysis proteins in cancer development
  51. Communications
  52. In vitro plant regeneration of Zenia insignis Chun
  53. DNA barcoding of online herbal supplements: crowd-sourcing pharmacovigilance in high school
  54. Case Reports
  55. Management of myasthenia gravis during pregnancy: A report of eight cases
  56. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
  57. Letters to the Editor
  58. First report of Chlamydia psittaci seroprevalence in black-headed gulls (Larus ridibundus) at Dianchi Lake, China
  59. Special Issue on Agricultural and Biological Sciences - Part II
  60. Chemical composition of essential oil in Mosla chinensis Maxim cv. Jiangxiangru and its inhibitory effect on Staphylococcus aureus biofilm formation
  61. Secondary metabolites of Antarctic fungi antagonistic to aquatic pathogenic bacteria
  62. Study of Seizure-Manifested Hartnup Disorder Case Induced by Novel Mutations in SLC6A19
  63. Transcriptome analysis of Pinus massoniana Lamb. microstrobili during sexual reversal
  64. Mechanism of oxymatrine-induced human esophageal cancer cell apoptosis by the endoplasmic reticulum stress pathway
  65. Methylation pattern polymorphism of cyp19a in Nile tilapia and hybrids
  66. A Method of Biomedical Information Classification based on Particle Swarm Optimization with Inertia Weight and Mutation
  67. A novel TNNI3 gene mutation (c.235C>T/ p.Arg79Cys) found in a thirty-eight-year-old women with hypertrophic cardiomyopathy
  68. Remote Sensing-Based Extraction and Analysis of Temporal and Spatial Variations of Winter Wheat Planting Areas in the Henan Province of China
  69. Topical Issue on Precision Medicine
  70. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis
  71. IL-17 gene rs3748067 C>T polymorphism and gastric cancer risk: A meta-analysis
  72. Efficacy of Danhong injection on serum concentration of TNF-α, IL-6 and NF-κB in rats with intracerebral hemorrhage
  73. An ensemble method to predict target genes and pathways in uveal melanoma
  74. Evaluation of the quality of CT images acquired with smart metal artifact reduction software
  75. NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
  76. Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
  77. New progress in understanding the cellular mechanisms of anti-arrhythmic drugs
https://doi.org/10.1515/biol-2018-0037
Keywords for this article
Cervical Cancer; Diffusion-Weighted Imaging (DWI); Radiation; Chemotherapy
Creative Commons
BY-NC-ND 4.0

Articles in the same Issue

  1. Research Article
  2. Purification of Tea saponins and Evaluation of its Effect on Alcohol Dehydrogenase Activity
  3. Runt-related transcription factor 3 promoter hypermethylation and gastric cancer risk: A meta-analysis
  4. Risk Factors for Venous Thromboembolism in Hospitalized Patients in the Chinese Population
  5. Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism
  6. A new combination of substrates: biogas production and diversity of the methanogenic microorganisms
  7. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
  8. Direct Effects on Seed Germination of 17 Tree Species under Elevated Temperature and CO2 Conditions
  9. Role of water soluble vitamins in the reduction diet of an amateur sportsman
  10. Aberrant DNA methylation involved in obese women with systemic insulin resistance
  11. 16S ribosomal RNA-based gut microbiome composition analysis in infants with breast milk jaundice
  12. Characterization of Haemophilus parasuis Serovar 2 CL120103, a Moderately Virulent Strain in China
  13. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45
  14. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
  15. Optimizing the Formulation for Ginkgolide B Solid Dispersion
  16. Determination of the In Vitro Gas Production and Potential Feed Value of Olive, Mulberry and Sour Orange Tree Leaves
  17. Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells
  18. The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
  19. Chemical profile and antioxidant activity of Trollius europaeus under the influence of feeding aphids
  20. SSR Markers Suitable for Marker Assisted Selection in Sunflower for Downy Mildew Resistance
  21. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
  22. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
  23. Microbial indicators and environmental relationships in the Umhlangane River, Durban, South Africa
  24. TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
  25. Long non-coding RNA-2271 promotes osteogenic differentiation in human bone marrow stem cells
  26. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid
  27. Risk expansion of Cr through amphibious clonal plant from polluted aquatic to terrestrial habitats
  28. Overexpression of Zinc Finger Transcription Factor ZAT6 Enhances Salt Tolerance
  29. Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
  30. Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
  31. A Preliminary Study on the Newly Isolated High Laccase-producing Fungi: Screening, Strain Characteristics and Induction of Laccase Production
  32. Hydrolytic Enzyme Production by Thermophilic Bacteria Isolated from Saudi Hot Springs
  33. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  34. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/ AKT pathways
  35. Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer
  36. Inhibitory activities of ethanolic extracts of two macrofungi against eggs and miracidia of Fasciola spp.
  37. PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
  38. Characterization of a potential ripening regulator, SlNAC3, from Solanum lycopersicum
  39. Expression of Angiopoietin and VEGF in cervical cancer and its clinical significance
  40. Umbilical Cord Tissue Derived Mesenchymal Stem Cells Can Differentiate into Skin Cells
  41. Isolation and Characterization of a Phage to Control Vancomycin Resistant Enterococcus faecium
  42. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
  43. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
  44. Relationship between climate trends and grassland yield across contrasting European locations
  45. Review Articles
  46. Mechanisms of salt tolerance in halophytes: current understanding and recent advances
  47. Salivary protein roles in oral health and as predictors of caries risk
  48. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
  49. Survival mechanisms to selective pressures and implications
  50. Up-regulation of key glycolysis proteins in cancer development
  51. Communications
  52. In vitro plant regeneration of Zenia insignis Chun
  53. DNA barcoding of online herbal supplements: crowd-sourcing pharmacovigilance in high school
  54. Case Reports
  55. Management of myasthenia gravis during pregnancy: A report of eight cases
  56. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
  57. Letters to the Editor
  58. First report of Chlamydia psittaci seroprevalence in black-headed gulls (Larus ridibundus) at Dianchi Lake, China
  59. Special Issue on Agricultural and Biological Sciences - Part II
  60. Chemical composition of essential oil in Mosla chinensis Maxim cv. Jiangxiangru and its inhibitory effect on Staphylococcus aureus biofilm formation
  61. Secondary metabolites of Antarctic fungi antagonistic to aquatic pathogenic bacteria
  62. Study of Seizure-Manifested Hartnup Disorder Case Induced by Novel Mutations in SLC6A19
  63. Transcriptome analysis of Pinus massoniana Lamb. microstrobili during sexual reversal
  64. Mechanism of oxymatrine-induced human esophageal cancer cell apoptosis by the endoplasmic reticulum stress pathway
  65. Methylation pattern polymorphism of cyp19a in Nile tilapia and hybrids
  66. A Method of Biomedical Information Classification based on Particle Swarm Optimization with Inertia Weight and Mutation
  67. A novel TNNI3 gene mutation (c.235C>T/ p.Arg79Cys) found in a thirty-eight-year-old women with hypertrophic cardiomyopathy
  68. Remote Sensing-Based Extraction and Analysis of Temporal and Spatial Variations of Winter Wheat Planting Areas in the Henan Province of China
  69. Topical Issue on Precision Medicine
  70. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis
  71. IL-17 gene rs3748067 C>T polymorphism and gastric cancer risk: A meta-analysis
  72. Efficacy of Danhong injection on serum concentration of TNF-α, IL-6 and NF-κB in rats with intracerebral hemorrhage
  73. An ensemble method to predict target genes and pathways in uveal melanoma
  74. Evaluation of the quality of CT images acquired with smart metal artifact reduction software
  75. NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
  76. Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
  77. New progress in understanding the cellular mechanisms of anti-arrhythmic drugs
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Winner of the OpenAthens UX Award 2026
Winner of the OpenAthens UX Award 2026
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 1.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2018-0037/html
Scroll to top button